Dr Reddy's Q4 net up 44% to Rs 434 cr, annual profit doubles to Rs 1,879 cr

Divestment of derma assets, lower operating costs helped firm post higher profit growth during the quarter

Drug major Dr Reddy's Laboratories Limited has reported a 44 per cent jump in consolidated net profit at Rs 434.3 crore for the quarter ended March, 2019, from Rs 302.2 crore in the same quarter a year ago. 

Divestment of derma assets and lower operating expenses helped the company in posting a higher profit growth during the quarter, it said.

Revenues grew by 14 per cent to 4,016.6 crore for the quarter under review helped by India and emerging markets even as the company was able to marginally improve its position in North America, which is its largest revenue base.